Mahesan Subramaniam: Pomegranate Juice and Heart Health
Mahesan Subramaniam, Co-Founder of United Health Tourism, Founder and Chief Executive Officer at TRI International group, posted on LinkedIn:
“Research shows pomegranate juice could slash artery blockages by up to 30%, offering a potent natural defense for heart health.
Recent clinical research has uncovered a powerful link between daily pomegranate juice consumption and a significant boost in heart health.
Scientists found that participants who enjoyed a single cup of the juice each day experienced up to a 30% reduction in arterial blockages. This impressive outcome is driven by punicalagins, unique antioxidants found in pomegranates that aggressively combat oxidative stress and inflammation within the blood vessels. By clearing these pathways, the juice serves as a natural defense mechanism against the buildup of plaque that leads to serious cardiovascular issues.
These findings suggest that simple dietary choices can have a profound impact on long-term wellness and disease prevention. Beyond improving blood flow, the regular intake of pomegranate juice supports overall vascular integrity, offering an accessible way to manage heart health without complex medical interventions. For anyone looking to optimize their cardiovascular system, adding this nutrient-dense beverage to a balanced diet provides a scientifically backed advantage. As the medical community increasingly recognizes the power of functional foods, the pomegranate is solidifying its reputation as a vital ally for a healthy heart.
Source:
Clinical Nutrition. Pomegranate juice consumption and its effects on cardiovascular health markers. Clinical Nutrition.”
Stay updated with Hemostasis Today.
-
Mar 24, 2026, 17:12Ron DePinho: CRISPR Progress in Cellular Immunotherapy
-
Mar 24, 2026, 17:12Martine Gilard։ Women’s Heart Health as a National Priority
-
Mar 24, 2026, 17:11Erik Nelson։ Blood Vessels – The Silent System That Determines How You Age
-
Mar 24, 2026, 17:10Anthony Yazbeck: Why the Hemolysin Test Matters More Than You Think
-
Mar 24, 2026, 17:09Marcos Gamboa Chele: Are We Asking for Too Many Thrombophilia Panels?
-
Mar 24, 2026, 17:06Anita Brikman: PPTA Explores India’s Growing Plasma-Derived Medicines Industry
-
Mar 24, 2026, 17:01Victor Canata: Is Embolectomy the Best Treatment for Pulmonary Thromboembolism?
-
Mar 24, 2026, 16:57Hossam Qassem: The Stepwise Investigation Framework for ICU Hemoglobin Drop
-
Mar 24, 2026, 16:56Alan Nurden: Targeting Splice Site Variants in Alport Syndrome with Antisense Therapy